Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3T MRI for TACE Response in HCC
NCT02057874Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Feb 2014
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Vanderbilt-Ingram Cancer Center. Primary endpoint: Correlation of Changes in Imaging Biomarkers (Ktrans, ADC, MTR, and APTasym) With Changes in Tumor Volume (mRECIST) at 12 weeks. Started Feb 2014; status: terminated.
Beyond the preview
Go deeper on NCT02057874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057874.